Sign up
Pharma Capital

The Hydroponics Company to change name to THC Global Group Limited

The medical cannabis company is vertically integrated from 'farm to pharma'.
global map showing market access through partnerships
The company's partnerships provide market access to four continents

The Hydroponics Company Ltd (ASX:THC) will put a resolution to its shareholders to change its name to THC Global Group Limited at its upcoming annual general meeting on 15 November 2018.

The change of company name will be one of 14 resolutions put to shareholders to vote on at the meeting.

Vertical integration, from farm to pharma

THC Global is a diversified global medical cannabis business that is vertically integrated from ‘farm to pharma’.

The vertical integration begins with a growing site in northern New South Wales and a growing, research and development facility in Queensland.

It then flows through to an industry-leading biopharmaceutical manufacturing facility ready for pharma-grade production.

Finally, THC Global has established international commercial partnerships with global industry leaders across Europe, Middle East, North America and Australia.

READ: The Hydroponics Company imported medicinal cannabis products available to Australian patients

During the current December quarter, THC Global aims to complete licencing and permitting activities on existing facilities and expand its product distribution.

View full THC profile View Profile
View All

Related Articles

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.